NASDAQ: TARA - Protara Therapeutics, Inc.

六个月盈利: +171.43%
部门: Healthcare

促销时间表 Protara Therapeutics, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020.

更多详情
The company is headquartered in New York, New York.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2014-10-22
ISIN US74365U1079
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.protaratx.com
Цена ао 4.15
每日价格变化: +0.1818% (5.5)
每周价格变化: +2.23% (5.39)
每月价格变化: +81.25% (3.04)
3个月内价格变化: +191.53% (1.89)
六个月内的价格变化: +171.43% (2.03)
每年价格变化: +193.87% (1.875)
3年内价格变化: -18.01% (6.72)
5年内价格变化: +1 627.27% (0.319)
10年价格变化: 0% (5.51)
年初以来价格变化: +117.79% (2.53)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 0.3035 10
P/E 0 0
EV/EBITDA 0.3093 10
全部的: 5

效率

姓名 意义 年级
ROA, % -51.19 0
ROE, % -59.16 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.1263 10
全部的: 9.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 184.68 10
盈利能力 EPS, % 41.55 6
全部的: 7.2
更多详情

机构 体积 分享, %
Opaleye Management Inc. 2692594 23.55
Vanguard Group Inc 427612 3.74
Boxer Capital, LLC 209227 1.83
Baker Brothers Advisors, LLC 199671 1.75
Ikarian Capital, LLC 188664 1.65
Privium Fund Management (UK) Ltd 119730 1.05
Renaissance Technologies, LLC 113300 0.99
Geode Capital Management, LLC 78518 0.69
Bridgeway Capital Management, Inc. 64000 0.56
Citadel Advisors Llc 38035 0.33

ETF 分享, % 本年盈利能力, % 股息, %
iShares Micro-Cap ETF 0.00906 17.09 1.54048



导师 职称 支付 出生年份
Mr. Jesse Shefferman Co-founder, CEO, President & Director 1.02M 1972 (53 年)
Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D. Co-Founder, Senior VP & Chief Scientific Operations Officer 694.16k 1981 (44 年)
Mr. Patrick Fabbio M.B.A. Chief Financial Officer 696.62k 1968 (57 年)
Ms. Hannah Fry VP, Principal Accounting Officer & Controller N/A 1991 (34 年)
Ms. Mary J. Grendell General Counsel & Corporate Secretary N/A
Ms. Justine O'Malley Senior Vice President of Investor Relations & Corporate Affairs

地址: United States, New York. NY, 345 Park Avenue South - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.protaratx.com